doasense.de bewertung und analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /admin Disallow: /captcha Disallow: /menu Disallow: /imemail Sitemap: https://www.doasense.de/sitemap.xml | ||
Meta Tags
| Title | DOASENSE point-of-care test DOAC Dipstick for direct oral anticoagulants - Pioneering Point-of-Care |
| Description | DOASENSE - Home - Pioneering Point-of-Care Testing for Welcome to DOASENSE, an in vitro diagnostics company focused on developing novel and specific tests for Direct Oral Anti-Coagulants |
| Keywords | DOAC, NOAC, anticoagulants, point of care test, POCT, Rivaroxaban, Dabigatran, Apixaban, Edoxaban, Harenberg, IVD, blood clotting, Idarucizumab, antidot, new oral anticoagulants, direct oral anticoagulants, emergency medicine, bleeding, hemorrhage |
Server Information
| WebSite | |
| Host IP | 144.76.217.57 |
| Location | Germany |
Mehr zu entdecken
doasense.de bewertung
|
Euro€3,306
Zuletzt aktualisiert: 2022-07-04 16:41:56
doasense.de hat Semrush globalen Rang von 9,443,388. doasense.de hat einen geschätzten Wert von € 3,306, basierend auf seinen geschätzten Werbeeinnahmen. doasense.de empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in Germany mit der IP-Adresse 144.76.217.57. Laut SiteAdvisor ist doasense.de sicher zu besuchen. |
Verkehr & Wertschätzungen
| Kauf-/Verkaufswert | Euro€3,306 |
| Tägliche Werbeeinnahmen | Euro€83,752 |
| Monatlicher Anzeigenumsatz | Euro€28,101 |
| Jährliche Werbeeinnahmen | Euro€2,204 |
| Tägliche eindeutige Besucher | 551 |
| Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. | |
DNS Records
| Host | Type | TTL | Data |
| doasense.de. | A | 7199 | IP: 144.76.217.57 |
| doasense.de. | NS | 21600 | NS Record: robotns3.second-ns.com. |
| doasense.de. | NS | 21600 | NS Record: robotns2.second-ns.de. |
| doasense.de. | NS | 21600 | NS Record: ns1.first-ns.de. |
| doasense.de. | MX | 21600 | MX Record: 10 ucs-master1.ucs.doasense.de. |
| doasense.de. | MX | 21600 | MX Record: 50 mail.doasense.de. |
| doasense.de. | TXT | 21600 | TXT Record: spf2.0/pra include:ucs-master1.ucs.doasense.de -all |
| doasense.de. | TXT | 21600 | TXT Record: v=spf1 ip4:144.76.217.57 include:_spf.google.com ~all |
| doasense.de. | TXT | 21600 | TXT Record: spf2.0/pra include:mail.doasense.de -all |
| doasense.de. | TXT | 3600 | TXT Record: MS=AC38B6E4E16FE4F3019A9AEE204615FD44D1B237 |
| doasense.de. | TXT | 3600 | TXT Record: M141-O516-P171 |
HtmlToTextCheckTime:2022-07-04 16:41:56
| DOASENSE - Home - Pioneering Point-of-Care Testing for DOACs × Home Products Resources Company Meet Us Contact Go to content Follow @DoasenseTest NEWS FLASH: 2022-05: Editorial emphasizes the relevance of the DOAC Dipstick test [ read more ] 2022-03: Latest data on the DOASENSE DOAC point-of-care test presented at GTH 202 2 , honored with Best Poster award [ review congress presentations ] 2022-02: DOAC Dipstick testing can reliably exclude the presence of clinically relevant DOAC concentrations in plasma [ download open access paper ] 2022-01: DOASENSE announces new partnership with Mediq as appointed exclusive distributor for Estonia [ read more ] 2021-12: V alue of DOASENSE’s rapid POC test for DOACs mentioned in Australasian Anaesthesia Blue Book [ download the Blue Book and refer to page 150] 2021-09: First meta-analysis published on DOAC Dipstic k for detection of Direct Oral Anticoagulants in patient urine samples [ download open access paper ] 2021-05: DOASENSE rapid test |
HTTP Headers
HTTP/1.1 302 Found Date: Mon, 04 Jul 2022 08:31:46 GMT Server: Apache/2.4.38 (Univention) Location: https://doasense.de/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Mon, 04 Jul 2022 08:31:46 GMT Server: Apache/2.4.38 (Univention) Last-Modified: Wed, 11 May 2022 08:35:46 GMT ETag: "6e80-5deb853e92ba0" Accept-Ranges: bytes Content-Length: 28288 Vary: Accept-Encoding Content-Type: text/html |